Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.49 [0.33-0.71],0.000152079894189237,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE6,Ribonuclease K6,Inverse variance weighted,15,0.83 [0.74-0.93],0.00181401556178758,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSS,Cathepsin S,Inverse variance weighted,23,0.84 [0.75-0.95],0.0044550406760103,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.65 [0.48-0.88],0.00562130826363983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.25 [1.07-1.47],0.00655086506791043,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.47 [1.11-1.95],0.00742732755352696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.76 [1.16-2.69],0.00850906468108732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.87 [0.78-0.96],0.00875690831831518,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHGB,Secretogranin-1,Inverse variance weighted,27,1.14 [1.03-1.27],0.00974226116762357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.88 [0.8-0.97],0.00975559302270965,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,1.1 [1.02-1.18],0.0121125437179037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.74 [0.58-0.94],0.0152063007145801,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPON2,Spondin-2,Inverse variance weighted,4,0.73 [0.56-0.94],0.0165666167945485,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF1,Trefoil factor 1,Inverse variance weighted,8,1.3 [1.05-1.62],0.0169829031101274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,1.26 [1.04-1.52],0.0174266276025556,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GRN,Progranulin,Inverse variance weighted,7,0.79 [0.64-0.97],0.0228139833241682,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP7,Matrilysin,Inverse variance weighted,13,1.2 [1.02-1.41],0.025637305344883,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.55 [1.05-2.29],0.0258033170166588,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.23 [0.06-0.84],0.0265158218935549,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.34 [0.13-0.9],0.0291776603137862,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.96 [1.07-3.58],0.0292584557590202,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18,Interleukin-18,Inverse variance weighted,16,1.41 [1.03-1.93],0.0313771812104063,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PI3,Elafin,Inverse variance weighted,10,0.82 [0.69-0.98],0.0329062443948056,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,2.2 [1.06-4.56],0.0339284053387864,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL27,C-C motif chemokine 27,Inverse variance weighted,4,1.3 [1.02-1.65],0.0345978492692153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.49 [1.02-2.16],0.037049663554014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD276,CD276 antigen,Inverse variance weighted,20,1.11 [1.01-1.23],0.0373575289994022,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,STC2,Stanniocalcin-2,Inverse variance weighted,3,1.97 [1.02-3.8],0.0426180399796933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.13 [1-1.28],0.0469268775622924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,1.35 [1-1.82],0.0470099812135003,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.88 [0.78-1],0.0487702207712263,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.35 [1-1.82],0.0499740337786141,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.89 [0.79-1],0.0517968090330231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PALM2,Paralemmin-2,Inverse variance weighted,8,0.79 [0.62-1],0.0530311800335014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,1.17 [1-1.38],0.0545154947235451,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,0.89 [0.8-1],0.0547203218963481,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.89 [0.8-1],0.0557180451264358,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,3.5 [0.96-12.7],0.0568703742951295,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SLAMF8,SLAM family member 8,Inverse variance weighted,25,1.06 [1-1.13],0.062741888069258,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.8 [0.63-1.01],0.0655214120820199,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.93 [0.94-3.95],0.0714337991023453,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.61 [0.95-2.74],0.076921664142711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C7,Complement component C7,Inverse variance weighted,38,1.07 [0.99-1.14],0.0841621526935279,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS9,Galectin-9,Inverse variance weighted,26,1.12 [0.98-1.27],0.0857874979664014,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP3,Stromelysin-1,Inverse variance weighted,34,1.14 [0.98-1.33],0.0883619840846778,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MVK,Mevalonate kinase,Inverse variance weighted,2,0.54 [0.27-1.1],0.0900174259064993,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLK11,Kallikrein-11,Inverse variance weighted,6,1.11 [0.98-1.26],0.0905871419644421,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GUCA2A,Guanylin,Inverse variance weighted,9,0.7 [0.47-1.06],0.091574799103666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.57 [0.92-2.67],0.0974976002166274,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.09 [0.98-1.2],0.102258622619414,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.71 [0.47-1.08],0.107288818920572,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.2 [0.96-1.49],0.111535652158498,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NRP2,Neuropilin-2,Inverse variance weighted,11,1.18 [0.96-1.44],0.11197002890605,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.79 [0.59-1.06],0.113628665177398,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.17 [0.96-1.43],0.114663406867416,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.4 [0.92-2.14],0.115542868424153,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PVR,Poliovirus receptor,Inverse variance weighted,27,0.94 [0.86-1.02],0.117154259980365,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,0.82 [0.63-1.06],0.121114058377917,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,0.91 [0.81-1.03],0.126633430136428,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.15 [0.96-1.37],0.131416128260196,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CFI,Complement factor I,Inverse variance weighted,6,0.82 [0.63-1.06],0.132220879978201,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.27 [0.93-1.73],0.13461888906306,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.78 [0.57-1.08],0.136403507063654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TMSB10,Thymosin beta-10,Wald ratio,1,0.46 [0.16-1.28],0.13662455852455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.3 [0.06-1.47],0.136915405568179,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,2.1 [0.79-5.61],0.137162137791242,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.85 [0.69-1.05],0.142089905504383,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.24 [0.93-1.66],0.142689998343142,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,0.9 [0.78-1.04],0.143253996508781,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.93 [0.84-1.03],0.144155329396243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,0.94 [0.87-1.02],0.146128608727175,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHGA,Chromogranin-A,Inverse variance weighted,3,0.8 [0.59-1.08],0.149944881714625,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,17,1.11 [0.96-1.28],0.15290370614147,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,1.17 [0.94-1.47],0.156932108832591,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.26 [0.91-1.75],0.157853947791198,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.11 [0.96-1.3],0.161279270456259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.78 [0.55-1.1],0.161945909009251,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.25 [0.91-1.72],0.166507315248304,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANG,Angiogenin,Inverse variance weighted,19,1.09 [0.96-1.24],0.169113834387763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Wald ratio,1,0.68 [0.4-1.18],0.172072566705085,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.78 [0.55-1.11],0.172618270844305,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,UMOD,Uromodulin,Inverse variance weighted,29,0.95 [0.88-1.02],0.173316860370404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CFD,Complement factor D,Inverse variance weighted,11,0.88 [0.72-1.06],0.174064302057146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.88 [0.72-1.06],0.176236931446589,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.88 [0.73-1.06],0.177955637658922,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.13 [0.95-1.34],0.178227074495157,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.73 [0.47-1.16],0.184897596599531,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,1.11 [0.95-1.31],0.185130019329747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,0.67 [0.37-1.21],0.186662477260887,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.89 [0.74-1.06],0.1869149293869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.78 [0.54-1.13],0.189419789770426,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.54 [0.81-2.95],0.191133596281746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.14 [0.94-1.39],0.193005286122663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,0.79 [0.55-1.13],0.196038358611233,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ELN,Elastin,Inverse variance weighted,2,0.34 [0.07-1.74],0.197104157971028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.36 [0.85-2.17],0.199333553109672,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.15 [0.93-1.44],0.201989233743166,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACY1,Aminoacylase-1,Inverse variance weighted,4,1.27 [0.88-1.82],0.203437130872729,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.82 [0.61-1.11],0.205788223018585,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL17C,Interleukin-17C,Inverse variance weighted,3,0.75 [0.48-1.17],0.20657499274869,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD302,CD302 antigen,Inverse variance weighted,9,0.87 [0.69-1.08],0.21195532289297,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.92 [0.81-1.05],0.212068390745524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSL,Cathepsin L1,Wald ratio,1,2.28 [0.62-8.38],0.214407065672362,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.13 [0.93-1.38],0.214468552298652,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.9 [0.69-5.27],0.216679768977278,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.1 [0.94-1.3],0.227635913171011,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CBLN4,Cerebellin-4,Inverse variance weighted,11,0.89 [0.74-1.08],0.228311775516594,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.07 [0.96-1.2],0.23046954378431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.75 [0.48-1.2],0.230582340842302,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD48,CD48 antigen,Inverse variance weighted,18,0.94 [0.85-1.04],0.231341035740512,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,1.29 [0.85-1.97],0.233868793607932,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CALB1,Calbindin,Inverse variance weighted,2,0.66 [0.33-1.31],0.234141234799016,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.22 [0.88-1.68],0.235009514607363,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL19,Interleukin-19,Inverse variance weighted,11,1.12 [0.93-1.35],0.239152637010802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.4 [0.8-2.46],0.239437945887603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,1.04 [0.97-1.11],0.241421246969191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.77 [0.5-1.19],0.242245517106827,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.26 [0.85-1.87],0.242825748130048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.74 [0.44-1.23],0.244304749488177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.78 [0.52-1.18],0.247407638826,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.85 [0.64-1.12],0.24877578876277,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.12 [0.92-1.37],0.25057336323598,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL10,Interleukin-10,Wald ratio,1,0.71 [0.4-1.28],0.256023540847867,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.88 [0.71-1.1],0.257502223907501,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,32,1.05 [0.96-1.15],0.266340986911053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,1.04 [0.97-1.12],0.268807491584976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,1.13 [0.91-1.39],0.270916278791062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSV,Cathepsin L2,Inverse variance weighted,11,1.13 [0.91-1.4],0.275156702454317,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,2.53 [0.48-13.44],0.276395207494326,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPO,Erythropoietin,Inverse variance weighted,5,1.64 [0.67-4.04],0.278975294666916,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.8 [0.62-5.22],0.279947574354243,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NECTIN4,Nectin-4,Inverse variance weighted,7,0.9 [0.74-1.09],0.281394743214364,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.19 [0.87-1.64],0.282863380549983,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TCN2,Transcobalamin-2,Inverse variance weighted,34,1.05 [0.96-1.15],0.284407710249276,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN3,CCN family member 3,Inverse variance weighted,19,0.91 [0.75-1.09],0.284744946104763,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.08 [0.94-1.23],0.286683575060028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,1.15 [0.89-1.5],0.287468255184197,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRSS8,Prostasin,Inverse variance weighted,5,0.78 [0.5-1.23],0.290501848299329,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.91 [0.77-1.08],0.290921510563473,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.94 [0.84-1.05],0.293199967228678,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.1 [0.92-1.3],0.295305195067402,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,0.83 [0.59-1.18],0.296931815193061,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CAPG,Macrophage-capping protein,Inverse variance weighted,33,0.93 [0.8-1.07],0.297364729582558,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,1.98 [0.55-7.13],0.29809496637178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.35 [0.77-2.36],0.298394180493728,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.1 [0.92-1.32],0.299117952364958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.85 [0.63-1.15],0.299695379110033,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.08 [0.93-1.26],0.306707152048545,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.46 [0.1-2.06],0.307207790242834,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.78 [0.48-1.27],0.310972416304001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.86 [0.65-1.15],0.315167461536909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.88 [0.68-1.13],0.31755825531945,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRSS2,Trypsin-2,Inverse variance weighted,3,0.82 [0.56-1.21],0.317720702854019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,0.95 [0.85-1.05],0.318997198213581,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.45 [0.09-2.16],0.320231267393406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,21,0.95 [0.85-1.06],0.320942067729344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.04 [0.96-1.12],0.325653441767526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,0.78 [0.47-1.29],0.326414143612782,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,7,1.25 [0.8-1.98],0.330409532045685,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE4,Ribonuclease 4,Inverse variance weighted,11,0.92 [0.78-1.09],0.330761574428026,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.78 [0.48-1.28],0.332790267153264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MUC13,Mucin-13,Inverse variance weighted,9,1.15 [0.86-1.54],0.333590765647231,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.1 [0.91-1.34],0.336601717105048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBP2,Retinol-binding protein 2,Wald ratio,1,1.62 [0.6-4.32],0.338562955702476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Inverse variance weighted,3,1.24 [0.79-1.95],0.341938137528182,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1.06 [0.94-1.19],0.344273382543444,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CSTB,Cystatin-B,Inverse variance weighted,28,0.94 [0.84-1.06],0.345287824073973,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.67 [0.29-1.54],0.345740193011162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.2 [0.82-1.76],0.346136997081224,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.95 [0.87-1.05],0.348751734513227,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.6 [0.2-1.77],0.35134078893483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Inverse variance weighted,3,0.77 [0.44-1.34],0.351764316178177,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.9 [0.73-1.12],0.355134230245108,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.52 [0.62-3.69],0.357230704022054,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,0.94 [0.82-1.08],0.36055257730174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,0.95 [0.86-1.06],0.36128224100924,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,0.96 [0.88-1.05],0.362269538541746,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.96 [0.89-1.04],0.362397002565207,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.13 [0.86-1.49],0.363453140978958,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,0.97 [0.9-1.04],0.364832663528366,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,1.13 [0.87-1.47],0.365019231832837,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.1 [0.89-1.37],0.368102420719309,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.91 [0.75-1.12],0.371738062548984,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,1.36 [0.69-2.66],0.372157063233894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.96 [0.88-1.05],0.372184096243599,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,3,1.35 [0.69-2.64],0.373714345700711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,0.95 [0.84-1.07],0.375693295350093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,0.93 [0.79-1.1],0.376036581172448,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.1 [0.89-1.37],0.381291193379579,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,9,1.09 [0.9-1.3],0.381929455335688,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,XCL1,Lymphotactin,Inverse variance weighted,31,0.96 [0.87-1.06],0.383126481494324,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.9 [0.72-1.13],0.383638441419244,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,0.88 [0.67-1.17],0.385751347345072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.08 [0.9-1.3],0.389900725755673,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.22 [0.77-1.93],0.393760762455117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,0.81 [0.49-1.33],0.397373710184731,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.97 [0.89-1.05],0.398976250254603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.13 [0.86-1.48],0.399103863082568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.1 [0.87-1.39],0.413703283943767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.93 [0.77-1.11],0.418492798749458,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Inverse variance weighted,27,1.06 [0.92-1.21],0.421106464860213,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.61 [0.18-2.05],0.422286628409569,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1.05 [0.93-1.19],0.422921082469286,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GLO1,Lactoylglutathione lyase,Inverse variance weighted,13,0.93 [0.78-1.11],0.42605681196399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTN,Pleiotrophin,Inverse variance weighted,4,1.23 [0.74-2.04],0.426080983585083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.86 [0.59-1.25],0.427524869760951,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,0.91 [0.72-1.15],0.428028168988404,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CALCA,Calcitonin,Inverse variance weighted,5,1.23 [0.73-2.06],0.432029658521603,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINB8,Serpin B8,Inverse variance weighted,28,0.97 [0.9-1.05],0.433316283950015,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.9 [0.68-1.18],0.434560474451662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,0.64 [0.21-1.96],0.435013489051647,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCG2,Secretogranin-2,Wald ratio,1,0.6 [0.17-2.15],0.435979770528619,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.87 [0.6-1.25],0.437226712286093,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.85 [0.55-1.29],0.438740570602316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VWC2,Brorin,Inverse variance weighted,22,1.06 [0.91-1.23],0.438743050110359,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.06 [0.92-1.22],0.438762109543988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,28,0.96 [0.86-1.07],0.43932646877912,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.69 [0.27-1.76],0.442675596636611,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.11 [0.85-1.43],0.443037415041614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,0.95 [0.82-1.09],0.44345238348914,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.8 [0.44-1.43],0.446475666428357,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.95 [0.85-1.08],0.447247052766565,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,1.15 [0.8-1.66],0.448484698549616,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FBLN2,Fibulin-2,Inverse variance weighted,11,1.06 [0.91-1.25],0.45061827302909,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OGN,Mimecan,Inverse variance weighted,30,0.95 [0.84-1.08],0.451789397510079,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.05 [0.92-1.2],0.457466978915748,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REN,Renin,Inverse variance weighted,4,1.11 [0.85-1.44],0.457563314406997,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,0.95 [0.83-1.09],0.459104916874007,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,9,1.07 [0.89-1.3],0.464332215664162,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.24 [0.7-2.19],0.467596830792662,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCRLB,Fc receptor-like B,Inverse variance weighted,61,0.97 [0.9-1.05],0.468325574845654,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.06 [0.9-1.26],0.470188763985561,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,0.94 [0.8-1.11],0.489101994277385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.08 [0.87-1.35],0.493733014686875,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,0.83 [0.49-1.41],0.496169551447119,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.93 [0.76-1.14],0.499781800987901,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.21 [0.69-2.1],0.503056768171574,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.19 [0.72-1.97],0.503781620380464,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,0.83 [0.49-1.43],0.505001752405881,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NFASC,Neurofascin,Inverse variance weighted,15,0.95 [0.82-1.1],0.506160123998051,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,0.88 [0.6-1.29],0.50676537873106,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AREG,Amphiregulin,Inverse variance weighted,3,0.88 [0.6-1.29],0.508550747609568,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.05 [0.92-1.19],0.511130316289526,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.95 [0.8-1.12],0.518363952089793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS4,Galectin-4,Inverse variance weighted,4,1.13 [0.78-1.64],0.519374878537431,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.93 [0.75-1.16],0.523316239318171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COLEC12,Collectin-12,Inverse variance weighted,11,1.08 [0.84-1.39],0.535872589436684,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,0.96 [0.84-1.1],0.538476630895693,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPTL2,Angiopoietin-related protein 2,Wald ratio,1,1.57 [0.37-6.65],0.539624984342259,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.87 [0.57-1.35],0.54057173101118,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.06 [0.87-1.3],0.543889769687982,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.36 [0.51-3.64],0.544827333597371,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FOLR1,Folate receptor alpha,Inverse variance weighted,5,0.89 [0.6-1.31],0.545290333535521,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,0.98 [0.92-1.05],0.547518090161084,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.91 [0.67-1.24],0.549268196416308,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.04 [0.91-1.2],0.551377806346898,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.1 [0.8-1.52],0.552545509439018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,0.96 [0.84-1.1],0.553158672747552,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PSAP,Prosaposin,Inverse variance weighted,5,1.11 [0.78-1.59],0.553395363988562,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.93 [0.72-1.19],0.553501234018229,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,1.05 [0.89-1.25],0.554241181112456,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.08 [0.84-1.38],0.554419950010717,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.98 [0.9-1.06],0.558331029533995,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,1.04 [0.91-1.19],0.560258464922028,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.13 [0.75-1.7],0.568389156200815,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS3,Galectin-3,Inverse variance weighted,25,0.97 [0.86-1.09],0.573642674167879,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1.05 [0.89-1.23],0.574788364465634,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SEPTIN8,Septin-8,Inverse variance weighted,2,0.88 [0.57-1.37],0.576262519129245,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.86 [0.5-1.48],0.578956444664953,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.02 [0.95-1.09],0.581577997054645,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1.07 [0.85-1.34],0.582906848619624,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.88 [0.55-1.4],0.583178454897178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.04 [0.91-1.19],0.584765444758239,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.13 [0.72-1.78],0.58547494763564,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,0.91 [0.64-1.29],0.588112079960976,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.12 [0.74-1.69],0.598683745885019,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SELE,E-selectin,Inverse variance weighted,4,0.86 [0.49-1.51],0.599394723566116,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.18 [0.63-2.23],0.603116802026072,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFNL1,Interferon lambda-1,Wald ratio,1,1.44 [0.36-5.75],0.60462712921927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.06 [0.85-1.33],0.606469660383614,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,Wald ratio,1,1.36 [0.42-4.47],0.607875614767316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.96 [0.82-1.12],0.60994045453399,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.08 [0.8-1.45],0.610938270362347,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,1.09 [0.78-1.52],0.613557910478721,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,11,1.05 [0.87-1.27],0.614455421619755,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ALCAM,CD166 antigen,Inverse variance weighted,6,0.91 [0.62-1.32],0.614739062187954,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.11 [0.74-1.66],0.618952112635856,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.97 [0.88-1.08],0.623755664611001,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,0.9 [0.6-1.35],0.624977352752523,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.94 [0.72-1.22],0.629039110028761,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Inverse variance weighted,30,1.02 [0.95-1.08],0.630100248498256,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.04 [0.9-1.19],0.631299681096849,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Wald ratio,1,0.84 [0.4-1.74],0.63219930273659,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.04 [0.88-1.23],0.633085532857468,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.97 [0.87-1.09],0.634095712417298,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1.05 [0.86-1.29],0.63498567722841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.95 [0.79-1.16],0.636384569780381,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,0.98 [0.89-1.08],0.636673582699002,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.94 [0.74-1.2],0.638541124095959,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGA5,Integrin alpha-5,Wald ratio,1,0.79 [0.29-2.15],0.639892553742941,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,0.92 [0.65-1.31],0.643021150007104,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS1,Galectin-1,Inverse variance weighted,6,1.04 [0.87-1.25],0.645836095808626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,0.88 [0.51-1.51],0.646367539091663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,0.89 [0.54-1.46],0.646367539091663,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BSG,Basigin,Wald ratio,1,0.9 [0.59-1.39],0.648009189024292,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.93 [0.67-1.28],0.650296116272117,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CST3,Cystatin-C,Inverse variance weighted,10,0.96 [0.8-1.15],0.650731584978644,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.95 [0.74-1.21],0.65918759245171,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.19 [0.55-2.56],0.660199726953876,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.04 [0.87-1.25],0.665226118674164,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,18,0.96 [0.81-1.14],0.66763049682282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1.03 [0.91-1.16],0.669861541956499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.02 [0.93-1.13],0.669922777339757,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH1,Cadherin-1,Wald ratio,1,0.76 [0.21-2.74],0.671059661199918,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.97 [0.85-1.11],0.671805248051325,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.97 [0.82-1.13],0.672120625181597,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1.02 [0.92-1.14],0.672992097612886,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.09 [0.74-1.6],0.673191890356952,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN5,CCN family member 5,Inverse variance weighted,8,1.11 [0.69-1.79],0.673192056437595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.89 [0.52-1.52],0.676900022080055,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.09 [0.72-1.64],0.679094950780859,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP8,Neutrophil collagenase,Inverse variance weighted,17,0.97 [0.83-1.13],0.680392858504787,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.75 [0.19-2.97],0.684874487802747,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.08 [0.74-1.58],0.685187713467751,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD27,CD27 antigen,Inverse variance weighted,9,0.96 [0.81-1.15],0.686293726414818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.96 [0.79-1.16],0.687956654953843,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.89 [0.49-1.6],0.689137160579515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,1.1 [0.68-1.79],0.689399695372894,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH3,Cadherin-3,Inverse variance weighted,2,1.15 [0.57-2.3],0.6916829577435,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD83,CD83 antigen,Inverse variance weighted,5,1.06 [0.79-1.44],0.693075330608701,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.91 [0.59-1.43],0.695137361969285,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL15,Interleukin-15,Wald ratio,1,3.17 [0.01-1047.12],0.696493667530687,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,4,1.08 [0.72-1.64],0.698439958775722,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RSPO1,R-spondin-1,Inverse variance weighted,5,1.06 [0.77-1.46],0.700314074415434,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.02 [0.93-1.12],0.701083863337499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,1.07 [0.76-1.5],0.70200618595732,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TCOF1,Treacle protein,Wald ratio,1,0.8 [0.25-2.52],0.70211228503635,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGF,Placenta growth factor,Inverse variance weighted,2,0.67 [0.08-5.31],0.703879323448301,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,1.04 [0.84-1.3],0.70409689753767,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1.02 [0.92-1.12],0.704288884705666,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.93 [0.65-1.33],0.704651216021903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.87 [0.43-1.78],0.708342973629793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,0.93 [0.64-1.35],0.715194151162793,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD160,CD160 antigen,Inverse variance weighted,11,1.03 [0.89-1.19],0.71774797527606,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPON1,Spondin-1,Inverse variance weighted,21,0.97 [0.84-1.13],0.721065207999802,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.97 [0.82-1.15],0.721096974491896,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP5,Fatty acid-binding protein 5,Wald ratio,1,0.92 [0.6-1.42],0.72135678743839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.92 [0.59-1.44],0.72279349247756,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DDT,D-dopachrome decarboxylase,Inverse variance weighted,2,0.92 [0.59-1.44],0.723174396534313,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,0.99 [0.93-1.05],0.725326262877866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,1.03 [0.85-1.25],0.729470449035344,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.94 [0.68-1.31],0.729647806471,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,1.05 [0.81-1.36],0.730656895791173,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,UPB1,Beta-ureidopropionase,Inverse variance weighted,3,1.2 [0.42-3.45],0.733278633441388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLK4,Kallikrein-4,Inverse variance weighted,17,1.02 [0.9-1.16],0.735222705271841,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NECTIN2,Nectin-2,Inverse variance weighted,5,1.04 [0.84-1.28],0.73535532179818,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.16 [0.48-2.81],0.739625300099885,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.97 [0.78-1.19],0.740453279838707,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.05 [0.78-1.41],0.740453959900547,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLXNB2,Plexin-B2,Inverse variance weighted,27,0.99 [0.92-1.06],0.743015817078937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AMBP,Protein AMBP,Inverse variance weighted,3,0.94 [0.63-1.4],0.743968196044661,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.08 [0.66-1.79],0.750087945248727,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C19orf12,Protein C19orf12,Wald ratio,1,1.27 [0.28-5.67],0.753331702653857,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.08 [0.65-1.79],0.755879687628086,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.97 [0.79-1.19],0.757407232074895,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,30,0.98 [0.85-1.12],0.75779702307385,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.77 [0.15-3.97],0.757977646291156,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.98 [0.84-1.13],0.75951193970567,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,0.98 [0.84-1.13],0.761577361692266,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,1.03 [0.86-1.22],0.761804859950711,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.02 [0.91-1.14],0.764390214065225,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,1.02 [0.88-1.19],0.765274745186238,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,0.97 [0.8-1.18],0.771546415721992,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.9-1.08],0.773465562282528,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,4,1.05 [0.75-1.48],0.774852033125062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NRP1,Neuropilin-1,Inverse variance weighted,12,0.98 [0.83-1.15],0.777882637405068,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCN1,Ficolin-1,Inverse variance weighted,28,0.98 [0.87-1.11],0.778310977062866,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.03 [0.82-1.29],0.790375723573988,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,1.03 [0.84-1.25],0.791184650492947,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COCH,Cochlin,Inverse variance weighted,17,0.99 [0.9-1.08],0.795311775086247,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.09 [0.56-2.11],0.796708145100519,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.04 [0.78-1.39],0.796929731978938,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.2 [0.29-4.95],0.796955792555499,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MB,Myoglobin,Wald ratio,1,0.81 [0.16-3.99],0.797378077295178,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.98 [0.82-1.16],0.799938254367136,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.98 [0.82-1.17],0.800605202296031,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.06 [0.68-1.66],0.800893282763873,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,0.97 [0.74-1.26],0.801625855700036,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,1.05 [0.69-1.6],0.802495568850595,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.13 [0.41-3.15],0.808370998205795,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.11 [0.47-2.66],0.810828787057006,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,0.96 [0.72-1.3],0.812024294460134,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DSC2,Desmocollin-2,Inverse variance weighted,9,1.02 [0.84-1.25],0.812146370201053,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.02 [0.88-1.18],0.812511501257768,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.95 [0.62-1.46],0.813468248355839,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH15,Cadherin-15,Inverse variance weighted,18,0.98 [0.84-1.15],0.814498256337425,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC3B,Tetranectin,Inverse variance weighted,7,1.03 [0.8-1.32],0.81675420653641,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,0.99 [0.88-1.1],0.817590458447848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.95 [0.61-1.49],0.820681102705037,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,0.97 [0.77-1.23],0.821041626783356,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSD,Cathepsin D,Inverse variance weighted,17,0.98 [0.78-1.22],0.823358673277784,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,0.97 [0.77-1.23],0.825696629113615,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPP1,Osteopontin,Inverse variance weighted,8,1.05 [0.68-1.62],0.827898421423704,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.05 [0.68-1.6],0.831726669922337,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GFER,FAD-linked sulfhydryl oxidase ALR,Wald ratio,1,0.92 [0.42-2],0.83570902799649,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,1.02 [0.81-1.3],0.843787120322442,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THBD,Thrombomodulin,Inverse variance weighted,5,1.03 [0.77-1.38],0.843824993996933,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.91-1.12],0.844228910082124,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OSM,Oncostatin-M,Wald ratio,1,1.09 [0.46-2.59],0.844759331949183,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,1.02 [0.85-1.22],0.844801327449413,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.01 [0.88-1.17],0.846027234610214,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIAE,Sialate O-acetylesterase,Inverse variance weighted,3,0.96 [0.66-1.41],0.847297705622927,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.09 [0.43-2.75],0.85275755017062,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,0.98 [0.82-1.18],0.85323910575903,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,0.85 [0.16-4.56],0.853524669005937,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.01 [0.9-1.13],0.854053312002195,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1.02 [0.82-1.27],0.856200958422018,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.81 [0.08-8.07],0.856371292764642,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1.03 [0.78-1.35],0.857398832782813,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.95 [0.54-1.66],0.857647615428131,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL4,C-C motif chemokine 4,Inverse variance weighted,18,1.02 [0.85-1.22],0.860774015974048,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.01 [0.91-1.12],0.86176242602412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,1.01 [0.92-1.1],0.86281737230515,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN4,CCN family member 4,Inverse variance weighted,27,0.99 [0.89-1.1],0.86405928508554,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD46,Membrane cofactor protein,Wald ratio,1,0.94 [0.48-1.86],0.868768206821635,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.96 [0.63-1.48],0.870261954642884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,13,1.01 [0.86-1.19],0.870702488089483,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MDK,Midkine,Inverse variance weighted,4,0.97 [0.65-1.44],0.870705491359159,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.03 [0.69-1.54],0.872184391083476,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.99 [0.84-1.16],0.873723401835452,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.04 [0.61-1.78],0.87561885151316,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RETN,Resistin,Inverse variance weighted,9,1.01 [0.84-1.23],0.881449508012386,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGA11,Integrin alpha-11,Inverse variance weighted,8,0.98 [0.76-1.26],0.88197072980264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.02 [0.81-1.27],0.882240866626101,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.95 [0.49-1.85],0.882834024118863,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.01 [0.88-1.16],0.884986108651496,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,0.99 [0.85-1.16],0.885519074611146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,0.92 [0.29-2.93],0.888762632806944,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,14,0.99 [0.83-1.18],0.888932593107248,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGA4,Pepsin A-4,Inverse variance weighted,2,1.05 [0.47-2.35],0.895857026772901,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.97 [0.56-1.65],0.897515287466884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,0.93 [0.29-2.93],0.898357129549113,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.09 [0.27-4.34],0.902950037994188,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.02 [0.69-1.52],0.903359299232887,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,1.03 [0.6-1.79],0.909972574690584,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.07 [0.32-3.64],0.910144723440455,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,1.01 [0.81-1.27],0.91231599913622,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,0.99 [0.87-1.13],0.912721407939282,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TXNDC5,Thioredoxin domain-containing protein 5,Inverse variance weighted,3,1.04 [0.48-2.27],0.913127649323388,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.99 [0.76-1.28],0.915424033962169,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,8,0.99 [0.8-1.23],0.920254325813406,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EDN1,Endothelin-1,Inverse variance weighted,3,0.98 [0.69-1.39],0.924857018757897,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD7,T-cell antigen CD7,Inverse variance weighted,8,1.01 [0.85-1.19],0.925290441385017,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.01 [0.87-1.16],0.929766162617557,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GSN,Gelsolin,Inverse variance weighted,5,1.03 [0.53-2.02],0.930586303578884,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,1.03 [0.54-1.95],0.930967623058665,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH2,Cadherin-2,Inverse variance weighted,3,1.04 [0.41-2.62],0.935771565106726,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DPT,Dermatopontin,Inverse variance weighted,21,0.99 [0.84-1.18],0.937732624533333,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.03 [0.53-2],0.937774128002848,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OCLN,Occludin,Inverse variance weighted,2,1.04 [0.43-2.5],0.938351479823376,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LMNB2,Lamin-B2,Wald ratio,1,0.94 [0.21-4.16],0.938624462402592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.98 [0.55-1.72],0.939059824024637,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PENK,Proenkephalin-A,Inverse variance weighted,19,1.01 [0.86-1.17],0.941503412735814,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPPC,C-type natriuretic peptide,Wald ratio,1,0.95 [0.23-4],0.944373570035592,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,10,1.01 [0.85-1.19],0.945169769300412,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SDC1,Syndecan-1,Inverse variance weighted,2,0.96 [0.27-3.42],0.948171745655709,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.99 [0.8-1.23],0.948187054147059,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.02 [0.56-1.84],0.95552929560083,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.99 [0.72-1.37],0.957333179288749,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RSPO3,R-spondin-3,Inverse variance weighted,6,0.99 [0.69-1.43],0.968846098879174,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.99 [0.54-1.82],0.974563780606524,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGRN,Agrin,Inverse variance weighted,17,1 [0.81-1.23],0.975054104419191,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MFGE8,Lactadherin,Inverse variance weighted,11,1 [0.84-1.19],0.977269571516264,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1 [0.7-1.44],0.979154406589146,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAYN,Layilin,Inverse variance weighted,20,1 [0.84-1.19],0.98575957789122,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,9,1 [0.79-1.26],0.988814701073236,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1 [0.81-1.22],0.990977304811715,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1 [0.86-1.16],0.991546769110257,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THBS2,Thrombospondin-2,Inverse variance weighted,16,1 [0.86-1.16],0.995741870834626,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FUOM,Fucose mutarotase,Inverse variance weighted,3,1 [0.58-1.71],0.996354399099696,cis
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GPKOW,G-patch domain and KOW motifs-containing protein,Inverse variance weighted,2,3.93 [1.66-9.28],0.00181665246497204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,0.78 [0.66-0.92],0.00346488877546466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.94 [1.23-3.06],0.0046434683520984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,0.13 [0.03-0.55],0.00528131211839545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THBS2,Thrombospondin-2,Inverse variance weighted,15,1.38 [1.1-1.74],0.0056181002250128,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.72 [0.57-0.91],0.0066081222366742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,1.79 [1.15-2.79],0.00966408759964025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF1,Trefoil factor 1,Inverse variance weighted,14,1.26 [1.05-1.5],0.0107771822168106,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PI3,Elafin,Inverse variance weighted,18,0.81 [0.69-0.95],0.0117731864080688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.42 [0.2-0.87],0.020029466884787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE6,Ribonuclease K6,Inverse variance weighted,4,2.5 [1.15-5.43],0.0209222271341228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.81 [1.09-3.01],0.0217107871346406,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,1.58 [1.06-2.34],0.0235498619230589,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS9,Galectin-9,Inverse variance weighted,36,1.15 [1.02-1.31],0.0235566730858443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,0.75 [0.59-0.96],0.0236284611645893,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,0.52 [0.29-0.93],0.0264447501206597,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,1.37 [1.04-1.82],0.0267988293290104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,0.75 [0.58-0.97],0.0302287257752876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.39 [1.03-1.87],0.031625193457328,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.86 [0.75-0.99],0.0328951472598148,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.51 [1.03-2.21],0.034083421627211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,STC2,Stanniocalcin-2,Inverse variance weighted,10,1.48 [1.02-2.14],0.038529139787095,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,0.89 [0.8-0.99],0.038743288173355,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.33 [1.01-1.75],0.0412697756021306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.9 [0.81-1],0.0414907444139672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.52 [0.28-0.98],0.0445194408125277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.7 [1.01-2.86],0.0447444866714346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,0.4 [0.16-0.98],0.0450029661046934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL17C,Interleukin-17C,Inverse variance weighted,5,0.55 [0.31-0.99],0.0468170631794139,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSS,Cathepsin S,Inverse variance weighted,7,1.84 [1.01-3.36],0.0480788948752289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.42 [0.18-1],0.0497132011696742,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,1.64 [1-2.7],0.0520012743901655,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MDK,Midkine,Inverse variance weighted,14,0.73 [0.53-1],0.0523957615229534,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPTL2,Angiopoietin-related protein 2,Inverse variance weighted,12,1.33 [1-1.77],0.0529001804792493,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SDC1,Syndecan-1,Inverse variance weighted,12,0.75 [0.55-1.01],0.0580015868279844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,0.81 [0.66-1.01],0.0607219163245875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PALM2,Paralemmin-2,Inverse variance weighted,9,0.8 [0.63-1.01],0.0651816833422177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.36 [0.12-1.08],0.0674978145985206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.91 [0.83-1.01],0.0681222378146999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.92 [0.84-1.01],0.0686787489083189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.3 [0.08-1.1],0.0690517415484916,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTH,Parathyroid hormone,Inverse variance weighted,11,0.75 [0.55-1.02],0.0709767583239399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.61 [0.96-2.69],0.0716585391633026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.9 [0.81-1.01],0.0718780824646729,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.94 [0.94-4],0.0726689703131871,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.47 [0.96-2.25],0.0735215797841856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,0.79 [0.61-1.02],0.0746167765560455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD276,CD276 antigen,Inverse variance weighted,24,1.23 [0.98-1.54],0.0760198045198925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.27 [0.97-1.64],0.0771763316690228,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL28,C-C motif chemokine 28,Inverse variance weighted,30,1.18 [0.98-1.43],0.0821482484491679,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,17,0.77 [0.58-1.04],0.0843318703629346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.48 [0.94-2.32],0.0867273557297778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.43 [0.95-2.17],0.087648077443982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,1.1 [0.99-1.23],0.0904474585043116,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BRK1,Protein BRICK1,Inverse variance weighted,10,0.76 [0.56-1.05],0.093520660121661,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.22 [0.97-1.55],0.094729829060005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH3,Cadherin-3,Inverse variance weighted,10,0.72 [0.49-1.06],0.0955174285314196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGAV,Integrin alpha-V,Inverse variance weighted,10,1.41 [0.94-2.13],0.0962669869314038,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CST3,Cystatin-C,Inverse variance weighted,3,1.95 [0.87-4.39],0.105203438130777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL22,Interleukin-22,Inverse variance weighted,4,0.51 [0.22-1.16],0.109044713399162,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.81 [0.63-1.05],0.109878584680554,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,17,0.92 [0.84-1.02],0.111570768723641,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,2.01 [0.85-4.73],0.11176607433438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.75 [0.53-1.07],0.11412736165594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACY1,Aminoacylase-1,Inverse variance weighted,6,1.36 [0.92-2.01],0.122813805041002,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCN1,Ficolin-1,Inverse variance weighted,50,1.12 [0.97-1.29],0.123435129715815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF11,Tumor necrosis factor ligand superfamily member 11,Inverse variance weighted,19,1.15 [0.96-1.37],0.128526584162892,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.77 [0.56-1.08],0.131265596684796,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTN,Pleiotrophin,Inverse variance weighted,3,1.65 [0.86-3.15],0.132308697067528,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.33 [0.92-1.92],0.132439267946495,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.63 [0.35-1.15],0.133131933662918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,1.82 [0.83-3.99],0.134175074826325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSD,Cathepsin D,Inverse variance weighted,7,1.53 [0.88-2.68],0.135661594434604,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NRP2,Neuropilin-2,Inverse variance weighted,14,1.35 [0.91-1.99],0.138080314621183,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,0.83 [0.64-1.06],0.139736063159449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.68 [0.41-1.14],0.140931525962934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CSTB,Cystatin-B,Inverse variance weighted,23,0.91 [0.81-1.03],0.142228275621201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANG,Angiogenin,Inverse variance weighted,8,0.66 [0.38-1.15],0.142806566003178,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THBD,Thrombomodulin,Inverse variance weighted,11,1.2 [0.94-1.52],0.146602534493621,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.38 [0.89-2.13],0.152347802721335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IMMT,MICOS complex subunit MIC60,Wald ratio,1,2.09 [0.76-5.78],0.153690510766594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.5 [0.86-2.63],0.155847619197067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OCLN,Occludin,Inverse variance weighted,2,1.87 [0.79-4.42],0.156109117066184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.79 [0.79-4.06],0.162502929655808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.4 [0.87-2.23],0.162861491300876,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,0.74 [0.48-1.14],0.167187112481894,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.31 [0.89-1.91],0.168774696375325,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FBLN2,Fibulin-2,Inverse variance weighted,6,0.72 [0.46-1.15],0.170656376984346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SNRPB2,U2 small nuclear ribonucleoprotein B'',Inverse variance weighted,2,0.46 [0.15-1.4],0.172748368645092,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.65 [0.35-1.21],0.176049887204152,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1.1 [0.95-1.28],0.18464082830466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DTNB,Dystrobrevin beta,Inverse variance weighted,2,0.54 [0.22-1.34],0.184712309634442,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.32 [0.87-2],0.185320030214829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.26 [0.89-1.78],0.188760654781571,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CFI,Complement factor I,Wald ratio,1,3.36 [0.55-20.58],0.189790152371592,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.7 [0.41-1.2],0.190690201225185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGF,Placenta growth factor,Inverse variance weighted,5,0.73 [0.45-1.18],0.193413933780357,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,0.68 [0.38-1.22],0.193442944275786,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,1.58 [0.79-3.14],0.193881170783426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,0.82 [0.61-1.11],0.197096187537361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,UMOD,Uromodulin,Inverse variance weighted,34,1.15 [0.93-1.43],0.197212310435939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.3 [0.87-1.94],0.197582033941283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CBLN4,Cerebellin-4,Inverse variance weighted,17,0.89 [0.75-1.06],0.198167576885594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.86 [0.68-1.09],0.205935538291102,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.72 [0.43-1.2],0.20629249737431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,1.28 [0.87-1.89],0.206849194565635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD83,CD83 antigen,Inverse variance weighted,14,0.82 [0.6-1.12],0.208403733777247,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PENK,Proenkephalin-A,Inverse variance weighted,15,1.16 [0.92-1.47],0.209434201242062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.59 [0.26-1.36],0.216224779245327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,0.91 [0.79-1.05],0.217273125545345,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGA4,Pepsin A-4,Inverse variance weighted,7,0.75 [0.47-1.19],0.21857546098557,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,0.89 [0.75-1.07],0.218965652236276,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,3,1.39 [0.82-2.38],0.220559275515258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,0.44 [0.12-1.64],0.221460932074991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PSAP,Prosaposin,Inverse variance weighted,13,1.13 [0.93-1.37],0.221983089443179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.69 [0.38-1.25],0.226363065458697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.08 [0.95-1.22],0.22761264359843,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.7 [0.72-4.06],0.22778301652611,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,0.77 [0.51-1.17],0.22889358421232,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,1.44 [0.79-2.6],0.232226411716734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,Inverse variance weighted,16,1.18 [0.9-1.53],0.234324437026898,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.1 [0.94-1.3],0.2355696265776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.57 [0.74-3.34],0.237754041747844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NECTIN4,Nectin-4,Inverse variance weighted,4,1.67 [0.71-3.95],0.240323696808918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.88 [0.72-1.09],0.241663475668184,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.27 [0.85-1.91],0.244509068256865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPON1,Spondin-1,Inverse variance weighted,4,1.44 [0.78-2.66],0.247547163275359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP7,Matrilysin,Wald ratio,1,1.38 [0.8-2.39],0.248472169835009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,1.46 [0.77-2.79],0.24856058467583,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.07 [0.96-1.19],0.254359619570827,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.72 [0.41-1.27],0.254765435538366,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.82 [0.58-1.16],0.256927808788913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.5 [0.74-3.01],0.260737355443331,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSZ,Cathepsin Z,Inverse variance weighted,16,0.93 [0.81-1.06],0.263223222310488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCLY,Selenocysteine lyase,Inverse variance weighted,4,1.97 [0.6-6.48],0.265941705562924,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.65 [0.3-1.4],0.269257590705559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.37 [0.78-2.4],0.272901062441031,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,1.39 [0.77-2.53],0.275524205753481,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.7 [0.37-1.33],0.27616679185301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,1.27 [0.82-1.97],0.27616726244713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.69 [0.35-1.36],0.27777049302264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.8 [0.53-1.2],0.278568918132723,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,0.88 [0.7-1.11],0.28373249603278,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.87 [0.67-1.12],0.284910046224171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,0.83 [0.6-1.16],0.285815779104126,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",Inverse variance weighted,2,0.39 [0.07-2.25],0.289678794682502,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C19orf12,Protein C19orf12,Inverse variance weighted,3,1.43 [0.74-2.76],0.291397935439011,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS4,Galectin-4,Inverse variance weighted,15,1.08 [0.93-1.26],0.292554670601224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.08 [0.94-1.25],0.293536293160507,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC5,Sialic acid-binding Ig-like lectin 5,Wald ratio,1,2.22 [0.5-9.9],0.296092231299672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,57,0.95 [0.87-1.04],0.296141729668643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.35 [0.77-2.36],0.298394180493728,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.72 [0.39-1.33],0.29869588059482,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,Inverse variance weighted,5,0.85 [0.63-1.15],0.299695379110033,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPP1,Osteopontin,Inverse variance weighted,13,1.21 [0.84-1.74],0.299914237898072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1.29 [0.8-2.09],0.301301704534795,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,0.78 [0.49-1.25],0.302777888125637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,1.2 [0.85-1.69],0.305250140384952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.82 [0.56-1.2],0.305343891963572,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.11 [0.91-1.35],0.307231779989918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.69 [0.34-1.41],0.307264875533301,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.28 [0.8-2.05],0.30755645944921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,0.82 [0.56-1.2],0.310967678986436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCG2,Secretogranin-2,Inverse variance weighted,2,0.68 [0.32-1.44],0.311010693371149,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAYN,Layilin,Inverse variance weighted,3,1.53 [0.67-3.5],0.311299981511901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,1.17 [0.86-1.6],0.317059758475901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.12 [0.9-1.39],0.319040970943132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.96 [0.88-1.04],0.319361573118943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.63 [0.25-1.57],0.319880493322426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,0.47 [0.1-2.11],0.322916991535255,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.78 [0.48-1.27],0.323147792572383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,0.82 [0.55-1.22],0.32640634662053,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.29 [0.78-2.13],0.327460692936096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.67 [0.31-1.49],0.328660796441937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC3B,Tetranectin,Inverse variance weighted,2,1.71 [0.58-5.07],0.330881683994725,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN3,CCN family member 3,Inverse variance weighted,17,0.92 [0.77-1.09],0.333524591901693,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.24 [0.8-1.93],0.333556609696879,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,0.88 [0.67-1.15],0.337076035210837,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,1.16 [0.86-1.56],0.339842768698938,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.18 [0.84-1.66],0.34540290465947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.24 [0.79-1.96],0.346538279873989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS3BP,Galectin-3-binding protein,Inverse variance weighted,30,1.07 [0.92-1.25],0.347422366280564,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,0.8 [0.5-1.28],0.349028171541453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.22 [0.81-1.84],0.351039282808032,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,0.97 [0.9-1.04],0.352074487961286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.36 [0.71-2.6],0.354160762792286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.06 [0.94-1.2],0.35620928911082,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.58 [0.18-1.85],0.356978948589874,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,0.95 [0.86-1.06],0.357815733963103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.79 [0.49-1.3],0.360123108936101,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LBR,Delta(14)-sterol reductase LBR,Inverse variance weighted,2,1.55 [0.61-3.96],0.360142541988201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1.15 [0.86-1.54],0.361744611286294,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SEPTIN8,Septin-8,Inverse variance weighted,4,0.71 [0.34-1.48],0.363112656154619,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.14 [0.86-1.51],0.36363471308809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINB8,Serpin B8,Inverse variance weighted,29,0.97 [0.9-1.04],0.364558297960379,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.92 [0.77-1.1],0.370601952214652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.85 [0.59-1.22],0.3709414990444,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD302,CD302 antigen,Inverse variance weighted,11,0.85 [0.59-1.22],0.37095964027151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.45 [0.64-3.27],0.372216471823099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.83 [0.55-1.26],0.37322757676016,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.18 [0.82-1.69],0.38123262516823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.77 [0.43-1.38],0.38140818896198,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.1 [0.89-1.37],0.386314407701437,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.72 [0.34-1.51],0.386974218266453,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.11 [0.87-1.41],0.388768438574479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,0.94 [0.82-1.08],0.391412072012929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSV,Cathepsin L2,Inverse variance weighted,34,1.07 [0.91-1.27],0.397628004317248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GLA,Alpha-galactosidase A,Inverse variance weighted,2,0.7 [0.3-1.61],0.397796281497965,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,1.06 [0.92-1.22],0.402783601360652,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRSS8,Prostasin,Inverse variance weighted,14,0.89 [0.67-1.18],0.405191935518532,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.23 [0.75-2],0.410846725977821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,12,1.08 [0.9-1.29],0.41224623714594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.66 [0.24-1.79],0.417032938383959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,1.16 [0.8-1.69],0.42044790600878,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH1,Cadherin-1,Inverse variance weighted,16,0.93 [0.77-1.12],0.421263173502531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.14 [0.83-1.58],0.422485407936191,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.1 [0.87-1.4],0.422707302479201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.1 [0.87-1.41],0.425276203028151,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,0.91 [0.73-1.14],0.427734818043933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.13 [0.83-1.54],0.429687752344436,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.16 [0.81-1.65],0.430633236731227,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.92 [0.74-1.14],0.432166704300164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.75 [0.36-1.55],0.434067350780822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.18 [0.78-1.8],0.434894855869512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.93 [0.76-1.13],0.437823822886616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,1.17 [0.78-1.76],0.439630917533917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.58 [0.15-2.29],0.440652058053097,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.93 [0.78-1.12],0.443102425340726,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,1.25 [0.7-2.23],0.444750369618804,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.8 [0.44-1.43],0.445971414186782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.94 [0.8-1.11],0.450308704370418,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.11 [0.85-1.44],0.452758062476497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,1.25 [0.7-2.22],0.457104031256612,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,1.09 [0.87-1.35],0.45839456078068,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SELE,E-selectin,Inverse variance weighted,20,1.04 [0.93-1.16],0.459017946215264,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DDT,D-dopachrome decarboxylase,Wald ratio,1,0.59 [0.15-2.41],0.462861287107302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.05 [0.92-1.21],0.464050701804614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,0.79 [0.42-1.49],0.465312504831629,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.06 [0.9-1.24],0.466962702255114,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.81 [0.46-1.44],0.4707728399882,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,0.85 [0.54-1.34],0.471661348215297,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,0.88 [0.62-1.24],0.47174243409858,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.69 [0.25-1.9],0.471999147735393,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.05 [0.92-1.18],0.474402756931327,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.96 [0.84-1.08],0.475969000466204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.89 [0.63-1.24],0.482583879445654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.53 [0.09-3.09],0.482950135262861,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GAST,Gastrin,Inverse variance weighted,9,0.88 [0.6-1.27],0.485568271705958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL18,Interleukin-18,Inverse variance weighted,26,0.94 [0.79-1.12],0.487016756887631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MFGE8,Lactadherin,Inverse variance weighted,15,1.12 [0.82-1.53],0.488434261586145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.17 [0.75-1.83],0.488706832211173,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,0.67 [0.22-2.07],0.489574030527122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.93 [0.75-1.15],0.494544825358387,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,19,0.95 [0.82-1.1],0.495093187691936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",Wald ratio,1,0.65 [0.18-2.27],0.495490206829822,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,0.82 [0.45-1.48],0.501527038161625,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,0.73 [0.28-1.85],0.501967592487767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1.12 [0.81-1.54],0.503883893560059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.87 [0.57-1.32],0.507465878411206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.87 [0.57-1.32],0.512061857512942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIAE,Sialate O-acetylesterase,Inverse variance weighted,6,0.82 [0.46-1.47],0.516115925525949,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.38 [0.52-3.67],0.516876784389391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.14 [0.77-1.69],0.517679269270562,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.9 [0.67-1.23],0.519046899081059,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,38,0.94 [0.77-1.14],0.520455638011099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,0.91 [0.7-1.2],0.521048228467717,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.09 [0.84-1.41],0.522661177474645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN5,CCN family member 5,Inverse variance weighted,12,1.07 [0.87-1.31],0.523327846675753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.81 [0.43-1.55],0.524266818718912,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,1.11 [0.81-1.52],0.530670093709884,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,1.54 [0.4-5.92],0.531569237468701,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TCOF1,Treacle protein,Wald ratio,1,0.64 [0.16-2.61],0.535499151697375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.79 [0.38-1.66],0.536053742837052,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CFD,Complement factor D,Wald ratio,1,1.49 [0.42-5.27],0.539992025927036,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.12 [0.78-1.61],0.541114977580768,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,1.03 [0.93-1.15],0.543954398993352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.36 [0.51-3.64],0.544827333597371,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.82 [0.44-1.55],0.547774842387447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.06 [0.88-1.28],0.55150676201945,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COCH,Cochlin,Inverse variance weighted,21,1.12 [0.77-1.62],0.553116427700566,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.12 [0.78-1.6],0.554285591515905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FUOM,Fucose mutarotase,Inverse variance weighted,6,1.15 [0.72-1.84],0.555979407970009,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.15 [0.72-1.86],0.559422736037099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH15,Cadherin-15,Inverse variance weighted,4,0.74 [0.27-2.04],0.561492738690659,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.1 [0.8-1.49],0.562488317259284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.9 [0.62-1.3],0.568649538886487,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGA5,Integrin alpha-5,Inverse variance weighted,18,1.07 [0.84-1.38],0.572868741724382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1.06 [0.87-1.28],0.573045546079246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.11 [0.76-1.63],0.575232850862668,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1.04 [0.9-1.22],0.57646521606204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CALCA,Calcitonin,Inverse variance weighted,13,1.11 [0.77-1.6],0.578079987794159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,1.12 [0.75-1.66],0.580705249024192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,1.33 [0.48-3.65],0.580917800047632,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,POF1B,Protein POF1B,Inverse variance weighted,4,1.29 [0.52-3.2],0.582460906664586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AREG,Amphiregulin,Inverse variance weighted,5,1.16 [0.68-1.99],0.585017675729103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RSPO1,R-spondin-1,Inverse variance weighted,8,1.1 [0.78-1.55],0.589436480725545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.37 [0.43-4.43],0.59509202550875,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,UPB1,Beta-ureidopropionase,Wald ratio,1,2.54 [0.08-79.84],0.596007951189099,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NRP1,Neuropilin-1,Inverse variance weighted,14,1.1 [0.78-1.54],0.597495818083981,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,0.81 [0.36-1.79],0.597574134321455,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.93 [0.71-1.22],0.597628635903599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.76 [0.27-2.14],0.598102839307063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.89 [0.58-1.37],0.602718395099088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFNL1,Interferon lambda-1,Inverse variance weighted,8,1.09 [0.78-1.52],0.604344892154233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PVR,Poliovirus receptor,Inverse variance weighted,3,1.25 [0.54-2.87],0.606955961931063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,10,1.07 [0.82-1.41],0.61272745106601,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPO,Erythropoietin,Inverse variance weighted,11,0.81 [0.36-1.83],0.613256519717088,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,0.95 [0.77-1.17],0.615566880249164,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MB,Myoglobin,Inverse variance weighted,9,0.9 [0.6-1.36],0.617183972150499,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,0.89 [0.57-1.4],0.621661078784243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.09 [0.77-1.55],0.622618775593142,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.93 [0.7-1.24],0.623401038327575,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,3,1.18 [0.61-2.27],0.627023869855856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.93 [0.68-1.26],0.627167265429029,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.94 [0.73-1.21],0.630091410298664,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.08 [0.79-1.48],0.630244574457594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD48,CD48 antigen,Inverse variance weighted,14,0.92 [0.64-1.32],0.637273087752932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ELN,Elastin,Inverse variance weighted,10,1.1 [0.74-1.64],0.641447555169844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP3,Stromelysin-1,Inverse variance weighted,4,0.83 [0.38-1.83],0.644458690954531,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHGB,Secretogranin-1,Inverse variance weighted,7,1.09 [0.76-1.55],0.64658573690146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,1.39 [0.34-5.75],0.64860201952118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.03 [0.89-1.19],0.654019348961399,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.32 [0.39-4.51],0.655014297117542,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.98 [0.91-1.06],0.656760321121169,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.91 [0.61-1.37],0.657696280761979,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MUC13,Mucin-13,Inverse variance weighted,3,0.83 [0.37-1.88],0.659762823910497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GUCA2A,Guanylin,Inverse variance weighted,7,0.92 [0.61-1.36],0.662629631455734,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.9 [0.57-1.44],0.666433176600708,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,0.89 [0.53-1.49],0.667037911402709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.17 [0.57-2.4],0.670963054108445,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LEP,Leptin,Inverse variance weighted,4,0.84 [0.36-1.94],0.677513900322923,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.26 [0.42-3.71],0.680983017277107,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHGA,Chromogranin-A,Inverse variance weighted,5,0.91 [0.59-1.42],0.681187770096282,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.91 [0.56-1.45],0.681690956128171,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.05 [0.83-1.32],0.6842808081237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL27,C-C motif chemokine 27,Inverse variance weighted,9,1.15 [0.58-2.3],0.68479185444096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NFASC,Neurofascin,Inverse variance weighted,6,1.12 [0.64-1.98],0.68847489741809,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,1.08 [0.73-1.6],0.690160567336182,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,C7,Complement component C7,Inverse variance weighted,26,0.98 [0.87-1.1],0.693785454971906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.16 [0.55-2.43],0.694481851832063,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.26 [0.4-4.02],0.695454358740203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.09 [0.71-1.69],0.695635109253932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,0.86 [0.4-1.83],0.695713950755104,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PTS,6-pyruvoyl tetrahydrobiopterin synthase,Wald ratio,1,1.36 [0.29-6.47],0.698066285012062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COLEC12,Collectin-12,Inverse variance weighted,3,1.24 [0.41-3.76],0.699218622188644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.04 [0.86-1.25],0.702585895186727,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.95 [0.71-1.26],0.702790517839185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.32 [0.31-5.68],0.705177411710252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,1.08 [0.73-1.6],0.705563964065375,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.95 [0.73-1.23],0.706979058516944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.13 [0.61-2.08],0.707505212327293,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.06 [0.79-1.42],0.709573888503413,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLXNB2,Plexin-B2,Inverse variance weighted,12,1.07 [0.73-1.58],0.715019219631426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD27,CD27 antigen,Inverse variance weighted,9,1.09 [0.69-1.7],0.715536204276721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.02 [0.92-1.13],0.717676411644246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FAM3B,Protein FAM3B,Inverse variance weighted,26,0.98 [0.88-1.1],0.724222996862599,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.93 [0.61-1.41],0.724240842783519,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.94 [0.67-1.33],0.727457096507381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.94 [0.68-1.32],0.730362813823914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.18 [0.46-3.06],0.731326460482467,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.77 [0.18-3.35],0.732436552247125,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.89 [0.45-1.76],0.733997843178176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.19 [0.43-3.32],0.734185474560257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCDH17,Protocadherin-17,Inverse variance weighted,44,1.02 [0.92-1.12],0.736526572134346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.09 [0.65-1.84],0.738267944211025,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.24 [0.35-4.39],0.739117657917654,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLK11,Kallikrein-11,Inverse variance weighted,13,1.05 [0.78-1.42],0.739711603024918,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.14 [0.51-2.55],0.740748454087955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL11,Eotaxin,Inverse variance weighted,11,1.03 [0.85-1.26],0.746401836753346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LGALS3,Galectin-3,Inverse variance weighted,15,1.05 [0.79-1.38],0.746701197737324,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.14 [0.52-2.47],0.748642127231086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFSF14,Tumor necrosis factor ligand superfamily member 14,Inverse variance weighted,3,1.15 [0.47-2.82],0.752976963651711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,0.91 [0.49-1.67],0.753259770099346,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,0.96 [0.74-1.25],0.753362525663805,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",Inverse variance weighted,3,0.82 [0.24-2.8],0.757040195295954,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,8,0.95 [0.66-1.36],0.760059126722384,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NECTIN2,Nectin-2,Inverse variance weighted,3,1.28 [0.25-6.44],0.764037432276483,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL15,Interleukin-15,Inverse variance weighted,35,0.97 [0.82-1.16],0.764200054758917,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.95 [0.67-1.35],0.765675801248937,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ECHS1,"Enoyl-CoA hydratase, mitochondrial",Inverse variance weighted,5,1.05 [0.75-1.47],0.768340005168865,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINA3,Alpha-1-antichymotrypsin,Inverse variance weighted,2,1.14 [0.46-2.85],0.773742279214713,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.05 [0.73-1.51],0.775752905203952,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.04 [0.78-1.41],0.775944387727465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VWC2,Brorin,Inverse variance weighted,12,0.94 [0.61-1.45],0.77621224417157,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.09 [0.62-1.91],0.777146086037374,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,0.9 [0.43-1.88],0.784509573696479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.11 [0.49-2.51],0.793481050624248,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,0.93 [0.52-1.65],0.793501043497259,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.12 [0.49-2.53],0.794369296685588,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCN4,CCN family member 4,Inverse variance weighted,29,1.02 [0.89-1.16],0.794561461281791,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GOLM2,Protein GOLM2,Inverse variance weighted,14,0.98 [0.81-1.18],0.797937987232419,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,1.02 [0.87-1.19],0.799665286990653,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.04 [0.75-1.45],0.799948007006817,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.04 [0.78-1.37],0.8066158208546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AGRN,Agrin,Inverse variance weighted,14,0.96 [0.71-1.3],0.807139474797109,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,0.98 [0.8-1.19],0.808695703110306,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL4,C-C motif chemokine 4,Inverse variance weighted,37,0.99 [0.88-1.1],0.808863835520686,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MVK,Mevalonate kinase,Wald ratio,1,0.7 [0.04-12.93],0.810492399796706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.08 [0.58-2.02],0.810951352123568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD160,CD160 antigen,Inverse variance weighted,24,1.03 [0.82-1.3],0.813690363929517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.06 [0.65-1.73],0.815440979983267,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL6,Interleukin-6,Inverse variance weighted,6,0.97 [0.75-1.26],0.816790814729631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.02 [0.84-1.26],0.817999440888322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.08 [0.57-2.05],0.818331417292942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,F9,Coagulation factor IX,Inverse variance weighted,3,1.09 [0.52-2.28],0.821177241101901,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.04 [0.76-1.41],0.822907574110457,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.91 [0.39-2.11],0.823299564260955,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,WNT9A,Protein Wnt-9a,Wald ratio,1,1.21 [0.23-6.48],0.824036520917968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPON2,Spondin-2,Inverse variance weighted,3,0.91 [0.41-2.04],0.825006369271026,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.05 [0.68-1.63],0.82708881844821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LMNB2,Lamin-B2,Inverse variance weighted,8,1.05 [0.67-1.64],0.829584338718711,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.83 [0.16-4.39],0.830191831490807,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RETN,Resistin,Inverse variance weighted,19,0.97 [0.73-1.29],0.830413305824545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,0.95 [0.59-1.53],0.831557718358508,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.97 [0.74-1.27],0.833376016681595,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DSC2,Desmocollin-2,Inverse variance weighted,16,0.98 [0.8-1.19],0.834328935129075,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,0.96 [0.66-1.39],0.83506557518284,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CDH2,Cadherin-2,Inverse variance weighted,21,1.05 [0.65-1.71],0.837556324560233,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,0.98 [0.81-1.19],0.838400966062994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.94 [0.5-1.75],0.8415887366309,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.03 [0.74-1.44],0.842333290271361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REN,Renin,Inverse variance weighted,8,0.96 [0.62-1.47],0.842831621480648,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.06 [0.6-1.86],0.843081020790933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.95 [0.54-1.65],0.845276987042342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.1 [0.44-2.75],0.845485622221175,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.96 [0.61-1.51],0.848491850130838,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,0.94 [0.52-1.72],0.849929315177285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.88 [0.24-3.29],0.852305267091468,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OSM,Oncostatin-M,Inverse variance weighted,6,1.05 [0.64-1.71],0.852556151727765,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CPM,Carboxypeptidase M,Inverse variance weighted,19,0.97 [0.72-1.31],0.853888013286159,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.09 [0.44-2.66],0.854363415365939,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.05 [0.61-1.81],0.856711114179365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.06 [0.57-1.97],0.858399197597443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,0.98 [0.75-1.27],0.86169759937497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.94 [0.5-1.8],0.861985575676737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CTSL,Cathepsin L1,Inverse variance weighted,29,0.98 [0.81-1.2],0.865767218661538,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.06 [0.52-2.16],0.866208566541671,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SERPINF1,Pigment epithelium-derived factor,Wald ratio,1,0.88 [0.2-3.95],0.867109582272469,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,0.93 [0.41-2.14],0.868082178055466,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GRN,Progranulin,Inverse variance weighted,46,1.01 [0.91-1.12],0.868877546670517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.92 [0.36-2.37],0.87083582212709,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.04 [0.64-1.68],0.873463610446908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ALCAM,CD166 antigen,Inverse variance weighted,4,0.97 [0.65-1.44],0.875522004740217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.11 [0.3-4.18],0.876461788142936,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GSN,Gelsolin,Inverse variance weighted,7,1.04 [0.63-1.71],0.878276021537545,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,0.95 [0.49-1.86],0.881307039797642,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.99 [0.86-1.14],0.882772365839764,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.02 [0.79-1.32],0.887144469576221,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PPL,Periplakin,Inverse variance weighted,2,0.95 [0.43-2.08],0.889121168634645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.03 [0.7-1.51],0.890848321377721,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,7,0.97 [0.67-1.41],0.891725550510667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.02 [0.76-1.37],0.893225662404043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",Inverse variance weighted,4,1.06 [0.47-2.37],0.895234571888706,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,XCL1,Lymphotactin,Inverse variance weighted,15,1.02 [0.72-1.46],0.895393592902062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.98 [0.7-1.38],0.899874743304146,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HAO1,Hydroxyacid oxidase 1,Inverse variance weighted,6,0.96 [0.5-1.83],0.900313099391326,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.98 [0.74-1.31],0.901710066002396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.06 [0.44-2.54],0.902639582714473,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.01 [0.89-1.14],0.903473231883424,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OGN,Mimecan,Inverse variance weighted,37,0.99 [0.88-1.12],0.906422421928512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.96 [0.52-1.78],0.908615568707498,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.99 [0.89-1.11],0.91012113643903,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,0.98 [0.65-1.47],0.918285255132431,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CAPG,Macrophage-capping protein,Wald ratio,1,1.06 [0.35-3.22],0.919760997235925,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.99 [0.77-1.26],0.922195151881303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.03 [0.59-1.78],0.922653144094383,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.98 [0.62-1.55],0.923841806157281,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.06 [0.35-3.22],0.924381828128756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL10,Interleukin-10,Inverse variance weighted,4,0.99 [0.76-1.28],0.929801685098341,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",Inverse variance weighted,4,0.97 [0.46-2.04],0.931416039907335,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,7,0.98 [0.55-1.74],0.932097650314497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.07 [0.24-4.75],0.932414028034665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL19,Interleukin-19,Inverse variance weighted,10,1.01 [0.85-1.2],0.934098532751367,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.98 [0.67-1.45],0.936358812249203,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CFC1,Cryptic protein,Inverse variance weighted,11,0.99 [0.69-1.41],0.938516571715994,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CALB1,Calbindin,Inverse variance weighted,9,1.01 [0.71-1.44],0.938784964305622,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,DPT,Dermatopontin,Inverse variance weighted,4,0.97 [0.41-2.26],0.939491948061292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,1.05 [0.29-3.82],0.944131508607684,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.06 [0.22-5.18],0.945598359402808,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,1.01 [0.83-1.23],0.946144655555365,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.99 [0.64-1.53],0.946203645686645,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.02 [0.56-1.86],0.946443229204821,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.01 [0.87-1.16],0.94686825738158,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,KLK4,Kallikrein-4,Inverse variance weighted,5,0.98 [0.45-2.1],0.949862768383657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RSPO3,R-spondin-3,Inverse variance weighted,5,0.98 [0.5-1.91],0.95339453704931,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.99 [0.72-1.36],0.959831221458586,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,AMBP,Protein AMBP,Inverse variance weighted,5,0.99 [0.69-1.42],0.961749067717018,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CD7,T-cell antigen CD7,Inverse variance weighted,12,1 [0.85-1.16],0.961874377966773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.01 [0.68-1.49],0.964831996632303,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.01 [0.66-1.54],0.965433906150707,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",Wald ratio,1,1.03 [0.28-3.79],0.96719162059245,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,0.99 [0.77-1.29],0.969310668674999,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,0.99 [0.66-1.49],0.969452782816833,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1 [0.79-1.29],0.9705514017702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.02 [0.38-2.69],0.973398806930544,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,0.99 [0.6-1.64],0.974491697047512,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1 [0.74-1.33],0.97478245367594,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1 [0.74-1.36],0.977450832034302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,BSG,Basigin,Inverse variance weighted,6,0.99 [0.5-1.95],0.97763841049389,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,FCRLB,Fc receptor-like B,Inverse variance weighted,10,1 [0.7-1.44],0.978598862222798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,PRSS2,Trypsin-2,Inverse variance weighted,17,1 [0.79-1.27],0.983665606444712,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,1 [0.78-1.28],0.984106211958479,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,1 [0.44-2.28],0.991978549857458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.99 [0.06-16.03],0.994455261503631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",Wald ratio,1,1 [0.11-8.7],0.996863554789906,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1 [0.84-1.19],0.998065069171115,trans
